Fighting disease at 83 years old: SARS-CoV-2 survival and response to anti-PD-1 therapy in PD-L1 negative adenocarcinoma of the lung – case report
Saved in:
| Main Authors: | Maria Nedelcu, Adelina Silvana Dragomir, Elena Adriana Mateianu, Dana Lucia Stănculeanu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medichub Media
2022-01-01
|
| Series: | Oncolog-Hematolog.ro |
| Online Access: | http://www.medichub.ro/reviste-de-specialitate/oncolog-hematolog-ro/fighting-disease-at-83-years-old-sars-cov-2-survival-and-response-to-anti-pd-1-therapy-in-pd-l1-negative-adenocarcinoma-of-the-lung-case-report-id-6229-cmsid-68 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapy
by: Bo-Ya Li, et al.
Published: (2025-05-01) -
The Potential of PD-1 and PD-L1 as Prognostic and Predictive Biomarkers in Colorectal Adenocarcinoma Based on TILs Grading
by: Nur Rahmah Rasyid, et al.
Published: (2024-11-01) -
Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer
by: Hongshu Li, et al.
Published: (2025-04-01) -
Activity of Negative Regulation of the PD-1/PD-L1/PD-L2 T-Cell Response System in Patients with Pneumonia and Influenza A (H1N1)
by: A. V. Malyarchikov, et al.
Published: (2021-08-01) -
First-line treatment options for PD-L1-negative lung adenocarcinoma: a real-world analysis
by: Lijuan Chen, et al.
Published: (2025-06-01)